Clinical Trials for Melanoma
EA6141
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma. View Details.
Medical Oncology: 706.353.2990
Radiation Oncology: 706.548.0500
Surgical Oncology: 706.715.2430
Breast Health Program: 762.356.4780
Pharmacy: 706.353.4344
Referrals: 706.353.4346
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma. View Details.